Normal Human Serum Contains a Natural IgM Antibody Cytotoxic for Human Neuroblastoma Cells

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1996 Apr 30

PMID 8633097

Citations 8

Authors

M W Ollert

K David

C Schmitt

A Hauenschild

R Bredehorst

R Erttmann

C W Vogel

Affiliations

Soon will be listed here.

Abstract

Neuroblastoma (NB) is characterized by the second highest spontaneous regression of any human malignant disorder, a phenomenon that remains to be elucidated. In this study, a survey of 94 normal human adult sera revealed a considerable natural humoral cytotoxicity against human NB cell lines in approximately one-third of the tested sera of both genders. Specific cell killing by these sera was in the range of 40% to 95%. Serum cytotoxicity was dependent on an intact classical pathway of complement. By several lines of evidence, IgM antibodies were identified as the cytotoxic factor in the sera. Further analyses revealed that a 260-kDa protein was recognized by natural IgM of cytotoxic sera in Western blots of NB cell extracts. The antigen was expressed on the surface of seven human NB cell lines but not on human melanoma or other control tumor cell lines derived from kidney, pancreas, colon, bone, skeletal muscle, lymphatic system, and bone marrow. Furthermore, no reactivity was observed with normal human fibroblasts, melanocytes, and epidermal keratinocytes. The antigen was expressed in vivo as detected by immunohistochemistry in both the tumor of a NB patient and NB tumors established in nude rats from human NB cell lines. Most interestingly, the IgM anti-NB antibody was absent from the sera of 11 human NB patients with active disease. The anti-NB IgM also could not be detected in tumor tissue obtained from a NB patient. Collectively, our data suggest the existence of a natural humoral immunological tumor defense mechanism, which could account for the in vivo phenomenon of spontaneous NB tumor regression.

Citing Articles

L2pB1 Cells Contribute to Tumor Growth Inhibition.

Shibad V, Bootwala A, Mao C, Bader H, Vo H, Landesman-Bollag E Front Immunol. 2021; 12:722451.

PMID: 34630396 PMC: 8495424. DOI: 10.3389/fimmu.2021.722451.

Temporal clustering of neuroblastic tumours in children and young adults from Northern England.

Muirhead C, Tweddle D, Basta N, McNally R Environ Health. 2015; 14:72.

PMID: 26338008 PMC: 4558831. DOI: 10.1186/s12940-015-0058-z.

A novel IgM-H-ficolin complement pathway to attack allogenic cancer cells in vitro.

Lei X, Liu C, Azadzoi K, Li C, Lu F, Xiang A Sci Rep. 2015; 5:7824.

PMID: 25592840 PMC: 4296296. DOI: 10.1038/srep07824.

Neuroblastoma: developmental biology, cancer genomics and immunotherapy.

Cheung N, Dyer M Nat Rev Cancer. 2013; 13(6):397-411.

PMID: 23702928 PMC: 4386662. DOI: 10.1038/nrc3526.

High level expression of functional human IgMs in human PER.C6 cells.

Tchoudakova A, Hensel F, Murillo A, Eng B, Foley M, Smith L MAbs. 2010; 1(2):163-71.

PMID: 20061826 PMC: 2725415. DOI: 10.4161/mabs.1.2.7945.

References

Bosslet K, Mennel H, Rodden F, Bauer B, Wagner F, Altmannsberger A . Monoclonal antibodies against epitopes on ganglioside GD2 and its lactones. Markers for gliomas and neuroblastomas. Cancer Immunol Immunother. 1989; 29(3):171-8. PMC: 11038022. DOI: 10.1007/BF00199992. View

Beckwith J, PERRIN E . IN SITU NEUROBLASTOMAS: A CONTRIBUTION TO THE NATURAL HISTORY OF NEURAL CREST TUMORS. Am J Pathol. 1963; 43:1089-104. PMC: 1949785. View

Schulz G, Bumol T, Reisfeld R . Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo. Proc Natl Acad Sci U S A. 1983; 80(17):5407-11. PMC: 384265. DOI: 10.1073/pnas.80.17.5407. View

Vogel C, MULLER-EBERHARD H . Cobra venom factor: improved method for purification and biochemical characterization. J Immunol Methods. 1984; 73(1):203-20. DOI: 10.1016/0022-1759(84)90045-0. View

Cheung N, Saarinen U, Neely J, Landmeier B, Donovan D, Coccia P . Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res. 1985; 45(6):2642-9. View

Hellstrom I, Hellstrom K, Pierce G, Bill A . Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc Natl Acad Sci U S A. 1968; 60(4):1231-8. PMC: 224908. DOI: 10.1073/pnas.60.4.1231. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Hellstrom K, Hellstrom I . Spontaneous tumor regression: possible relationship to in vitro parameters of tumor immunity. Natl Cancer Inst Monogr. 1976; 44:131-4. View

Noguchi P, Wallace R, Johnson J, Earley E, OBrien S, Ferrone S . Characterization of the WIDR: a human colon carcinoma cell line. In Vitro. 1979; 15(6):401-8. DOI: 10.1007/BF02618407. View

10.

Ueda R, Shiku H, Pfreundschuh M, Takahashi T, Li L, Whitmore W . Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med. 1979; 150(3):564-79. PMC: 2185656. DOI: 10.1084/jem.150.3.564. View

11.

Natoli Jr E, Livingston P, Pukel C, LLOYD K, Wiegandt H, Szalay J . A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivity. Cancer Res. 1986; 46(8):4116-20. View

12.

Reynolds J, Shou J, Choi H, Sigal R, ZIEGLER M, Daly J . The influence of natural killer cells in neuroblastoma. Arch Surg. 1989; 124(2):235-9. DOI: 10.1001/archsurg.1989.01410020109018. View

13.

Kipps T . The CD5 B cell. Adv Immunol. 1989; 47:117-85. DOI: 10.1016/s0065-2776(08)60663-x. View

14.

Ollert M, Calderone R . A monoclonal antibody that defines a surface antigen on Candida albicans hyphae cross-reacts with yeast cell protoplasts. Infect Immun. 1990; 58(3):625-31. PMC: 258511. DOI: 10.1128/iai.58.3.625-631.1990. View

15.

Ollert M, Frade R, Fiandino A, Panneerselvam M, Petrella E, Barel M . C3-cleaving membrane proteinase. A new complement regulatory protein of human melanoma cells. J Immunol. 1990; 144(10):3862-7. View

16.

Juhl H, Petrella E, Cheung N, Bredehorst R, Vogel C . Complement killing of human neuroblastoma cells: a cytotoxic monoclonal antibody and its F(ab')2-cobra venom factor conjugate are equally cytotoxic. Mol Immunol. 1990; 27(10):957-64. DOI: 10.1016/0161-5890(90)90118-j. View

17.

BOLANDE R, Mayer D . The cytolysis of human neuroblastoma cells by a natural IgM 'antibody'-complement system in pregnancy serum. Cancer Invest. 1990; 8(6):603-11. DOI: 10.3109/07357909009018927. View

18.

Avrameas S . Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today. 1991; 12(5):154-9. DOI: 10.1016/S0167-5699(05)80045-3. View

19.

Brodeur G, Moley J . Biology of tumors of the peripheral nervous system. Cancer Metastasis Rev. 1991; 10(4):321-33. DOI: 10.1007/BF00554794. View

20.

Ollert M, Kadlec J, Petrella E, Bredehorst R, Vogel C . Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65. Cancer Res. 1993; 53(3):592-9. View